- Home
- TXG vs DFIN Comparison
TXG vs DFIN Comparison
Compare TXG & DFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXG
- DFIN
- Stock Information
- Founded
- TXG 2012
- DFIN 1983
- Country
- TXG United States
- DFIN United States
- Employees
- TXG N/A
- DFIN N/A
- Industry
- TXG Biotechnology: Laboratory Analytical Instruments
- DFIN Other Consumer Services
- Sector
- TXG Industrials
- DFIN Consumer Discretionary
- Exchange
- TXG Nasdaq
- DFIN Nasdaq
- Market Cap
- TXG 1.7B
- DFIN 1.8B
- IPO Year
- TXG 2019
- DFIN N/A
- Fundamental
- Price
- TXG $13.36
- DFIN $54.25
- Analyst Decision
- TXG Buy
- DFIN Strong Buy
- Analyst Count
- TXG 11
- DFIN 3
- Target Price
- TXG $13.41
- DFIN $68.67
- AVG Volume (30 Days)
- TXG 3.6M
- DFIN 316.2K
- Earning Date
- TXG 08-07-2025
- DFIN 07-31-2025
- Dividend Yield
- TXG N/A
- DFIN N/A
- EPS Growth
- TXG N/A
- DFIN N/A
- EPS
- TXG N/A
- DFIN 2.79
- Revenue
- TXG $644,466,000.00
- DFIN $755,000,000.00
- Revenue This Year
- TXG N/A
- DFIN $1.91
- Revenue Next Year
- TXG $5.60
- DFIN $4.64
- P/E Ratio
- TXG N/A
- DFIN $19.47
- Revenue Growth
- TXG 2.02
- DFIN N/A
- 52 Week Low
- TXG $6.78
- DFIN $37.80
- 52 Week High
- TXG $24.76
- DFIN $70.55
- Technical
- Relative Strength Index (RSI)
- TXG 55.08
- DFIN 42.43
- Support Level
- TXG $12.85
- DFIN $51.18
- Resistance Level
- TXG $14.22
- DFIN $58.45
- Average True Range (ATR)
- TXG 0.94
- DFIN 2.61
- MACD
- TXG -0.09
- DFIN -0.04
- Stochastic Oscillator
- TXG 52.02
- DFIN 26.94
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
About DFIN Donnelley Financial Solutions Inc.
Donnelley Financial Solutions Inc is a risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( USA), Europe, Asia, Canada, and others, of which the USA accounts for the vast majority of its total revenue.